[Efficacy of immunomodulators in children with respiratory diseases in environmentally poor areas].
Gig Sanit
; (3): 33-4, 2012.
Article
en Ru
| MEDLINE
| ID: mdl-23088120
The authors evaluated the clinical efficacy and safety of the antiviral and immunomodulatory drug Isoprinosine (inosine pranobex, Teva Pharmaceutical Industries, Ltd) in the treatment of bronchopulmonary diseases in children. One hundred and fifty-two children with acute respiratory diseases and an exacerbation of recurrent respiratory diseases were followed up. The use of Isoprinosine in their combined treatment showed both positive clinical changes and a better immunogram.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedades Respiratorias
/
Adyuvantes Inmunológicos
/
Enfermedades Ambientales
/
Exposición a Riesgos Ambientales
/
Inmunomodulación
/
Inosina Pranobex
Tipo de estudio:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Child
/
Child, preschool
/
Humans
País/Región como asunto:
Asia
/
Europa
Idioma:
Ru
Revista:
Gig Sanit
Año:
2012
Tipo del documento:
Article
Pais de publicación:
Rusia